Skip to main content
OFIXOrthofix Medical Inc.Sell4.9·$10.74+14.87%
Open full analysis

Orthofix Medical Inc. (OFIX) Stock Analysis

Recovery setup · Inst Constrain edge

SellVALUE-TRAP 2/5Moderate Confidence

Healthcare · Medical Devices

Sell if holding. Momentum 4.3/10 is below the 5.0 floor at $10.74 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Weak overall score: 4.9/10; Weak growth.

Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction. The... Read more

$10.74+28.3% A.UpsideScore 4.9/10#52 of 64 Medical Devices
QualityF-score8 / 9FCF yield5.48%
Stop $9.24Target $12.75(analyst − 15%)A.R:R 2.6:1
Analyst target$15.00+39.7%4 analysts
$12.75our TP
$10.74price
$15.00mean
$18

Sell if holding. Momentum 4.3/10 is below the 5.0 floor at $10.74 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Weak overall score: 4.9/10; Weak growth. Chart setup: Death cross but MACD improving, RSI 60. Score 4.9/10, moderate confidence.

Passes 7/9 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, earnings proximity 31d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA). Suitability: speculative.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-07-05

Recent Developments — Orthofix Medical Inc.

Latest news

Generated 2026-07-05T09:50:25Z.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Tue, Aug 4, 202631d to earnings· next earnings call

Thesis

Rewards
Strong earnings beat streak (3/4)
Attractive valuation
Analyst upside: 28%
Risks
Weak overall score: 4.9/10
Weak growth
Below 200-MA, MA slope -4.8%/30d (confirmed downtrend)

Key Metrics

P/E (TTM)
P/E (Fwd)14.0
Mkt Cap$402M
EV/EBITDA32.0
Profit Mgn-7.3%
ROE-13.4%
Rev Growth1.6%
Beta0.71
DividendNone
Rating analysts11

Quality Signals

Piotroski F8/9

Options Flow

P/C0.20bullish
IV165%elevated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

3 floor-breakers

Growth below the gate floor. Component breakdown shows what dragged the score down.static

Revenue Growth
2.9
Low model confidence on this dimension (33%).

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

52w Position
1.7
Bollinger
2.2
Support Resistance
3.7
Gap
5.0

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Growth Rank
1.7
Quality Rank
3.5
Value Rank
9.5
GatesMomentum 4.3<4.5Death cross (50MA < 200MA)A.R:R 2.6 ≥ 1.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 31d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRecoverySuitability: Speculative
RSI
60 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $8.85Resistance $10.58

Price Targets

$9
$13
A.Upside+18.7%
A.R:R2.6:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! momentum at 4.3 (below the engine's 4.5 threshold)
! Death cross — 50-day MA below 200-day MA

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-08-04 (31d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is OFIX stock a buy right now?

Sell if holding. Momentum 4.3/10 is below the 5.0 floor at $10.74 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Weak overall score: 4.9/10; Weak growth. Chart setup: Death cross but MACD improving, RSI 60. Prior stop was $9.24. Score 4.9/10, moderate confidence.

What is the OFIX stock price target?

Take-profit target: $12.75 (+28.3% upside). Prior stop was $9.24. Stop-loss: $9.24.

What are the risks of investing in OFIX?

Weak overall score: 4.9/10; Weak growth; Below 200-MA, MA slope -4.8%/30d (confirmed downtrend).

Is OFIX overvalued or undervalued?

Orthofix Medical Inc. trades at a P/E of N/A (forward 14.0). TrendMatrix value score: 7.2/10. Verdict: Sell.

What do analysts say about OFIX?

11 analysts cover OFIX with a consensus score of 4.1/5. Average price target: $15.

What does Orthofix Medical Inc. do?Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States,...

Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulation devices that enhance bone fusion; designs, develops, and markets a portfolio of spine fixation implant products for use throughout the spinal column; and offers bone graft substitutes, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers in various forms with supporting graft delivery solutions to treat various spinal, orthopedic, and dental conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations; and 7D FLASH Navigation System, a navigation platform for spinal and cranial procedures. The Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market, including deformity correction, limb lengthening, complex fracture management, and limb preservation. This segment also designs, develops, and markets external and internal fixation limb reconstruction products that are coupled with enabling digital technologies to support the entire patient care continuum. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, healthcare providers, ambulatory surgery centers, and out-patient hospitals. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

Related stocks: DCTH (Delcath Systems, Inc.) · BWAY (Brainsway Ltd.) · TCMD (Tactile Systems Technology, Inc) · ATEC (Alphatec Holdings, Inc.) · MOBI (Mobia Medical, Inc.)
Home Stocks OFIX

Latest news

Latest News

Benzinga3d ago